本页面由Tiger Trade Technology Pte. Ltd.提供服务

Lyell Immunopharma, Inc.

13.89
+0.22001.61%
盘后:13.890.00000.00%17:19 EST
成交量:11.61万
成交额:162.34万
市值:4.45亿
市盈率:-1.23
高:14.49
开:13.57
低:13.40
收:13.67
52周最高:45.00
52周最低:7.20
股本:3,201.57万
流通股本:1,732.24万
量比:0.56
换手率:0.67%
股息:- -
股息率:- -
每股收益(TTM):-11.3197
每股收益(LYR):-16.0562
净资产收益率:-97.79%
总资产收益率:-36.90%
市净率:2.31
市盈率(LYR):-0.87

数据加载中...

2026/11/10

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/11/04

重要事件披露

Form 8-K - Current report
2026/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/11/04

重要事件披露

Form 8-K - Current report
2026/09/10

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/18

SEC问询函

Form CORRESP - Correspondence
2026/06/18

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/15

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/21

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/13

SEC问询函

Form CORRESP - Correspondence
2026/03/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]